Treatment of childhood Plasmodium falciparum malaria: current challenges

References

• Sina B. Focus on Plasmodium vivax. Trends Parasitol.18(7), 287–289 (2002).
   PubMedGoogle Scholar
• Lopez AD, Mathers CD, Ezzati M et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet367(9524), 1747–1757 (2006).
   PubMed Web of Science ®Google Scholar
• Breman JG. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg.64(1–2 Suppl.), 1–11 (2001).
   PubMed Web of Science ®Google Scholar
• Snow RW, Omumbo JA, Lowe B et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet349(9066), 1650–1654 (1997).
   PubMed Web of Science ®Google Scholar
• Snow RW, Craig M, Deichmann U et al. Estimating mortality, morbidity and disability due to malaria among Africa’s non-pregnant population. Bull. World Health Organ.77(8), 624–640 (1999).
   PubMed Web of Science ®Google Scholar
• Newton CR, Taylor TE, Whitten RO. Pathophysiology of fatal falciparum malaria in African children. Am. J. Trop. Med. Hyg.58(5), 673–683 (1998).
   PubMed Web of Science ®Google Scholar
• Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat. Rev. Microbiol.4(9 Suppl.), S7–S20 (2006).
   PubMed Web of Science ®Google Scholar
• Baird JK. Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann. Trop. Med. Parasitol.92(4), 367–390 (1998).
   PubMedGoogle Scholar
• Murray CK, Bell D, Gasser RA et al. Rapid diagnostic testing for malaria. Trop. Med. Int. Health8(10), 876–883 (2003).
   PubMed Web of Science ®Google Scholar
• Giha HA, Elbasit IE, Elgadir TM et al. Cerebral malaria is frequently associated with latent parasitemia among the semi-immune population of eastern Sudan. Microbes Infect.7(11–12), 1196–1203 (2005).
   PubMed Web of Science ®Google Scholar
• Biritwum RB, Welbeck J, Barnish G. Incidence and management of malaria in two communities of different socio-economic level, in Accra, Ghana. Ann. Trop. Med. Parasitol.94(8), 771–778 (2000).
   PubMed Web of Science ®Google Scholar
• Reyburn H, Mbatia R, Drakeley C et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. Br. Med. J.329(7476), 1212 (2004).
   PubMed Web of Science ®Google Scholar
• Wellems TE, Plowe CV. Chloroquine-resistant malaria. J. Infect. Dis.184(6), 770–776 (2001).
   PubMed Web of Science ®Google Scholar
• Plowe CV, Kublin JG, Dzinjalamala FK et al. Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. Br. Med. J.328(7439), 545 (2004).
   PubMed Web of Science ®Google Scholar
• Price RN, Uhlemann AC, Brockman A et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet364(9432), 438–447 (2004).
   PubMed Web of Science ®Google Scholar
• Sowunmi A, Falade CO, Oduola AM et al. Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg.92(4), 446–448 (1998).
   PubMed Web of Science ®Google Scholar
• Phillips-Howard PA, West LJ. Serious adverse drug reactions to pyrimethamine–sulphadoxine, pyrimethamine–dapsone and to amodiaquine in Britain. J. R. Soc. Med.83(2), 82–85 (1990).
   PubMed Web of Science ®Google Scholar
• Clarke JB, Neftel K, Kitteringham NR et al. Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine. Int. Arch. Allergy Appl. Immunol.95(4), 369–375 (1991).
   PubMedGoogle Scholar
• Wilairatana P, Kyle DE, Looareesuwan S et al. Poor efficacy of antimalarial biguanide–dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Ann. Trop. Med. Parasitol.91(2), 125–132 (1997).
   PubMed Web of Science ®Google Scholar
• Nzila A, Ochong E, Nduati E et al. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet? Trans. R. Soc. Trop. Med. Hyg.99(5), 341–346 (2005).
   PubMed Web of Science ®Google Scholar
• Watkins WM, Sibley CH, Hastings IM. The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations. Am. J. Trop. Med. Hyg.72(2), 163–173 (2005).
   PubMed Web of Science ®Google Scholar
• White NJ. Antimalarial drug resistance. J. Clin. Invest.113(8), 1084–1092 (2004).
   PubMed Web of Science ®Google Scholar
• Jambou R, Legrand E, Niang M et al. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet366(9501), 1960–1963 (2005).
   PubMed Web of Science ®Google Scholar
• Nosten F, van VM, Price R et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet356(9226), 297–302 (2000).
   PubMed Web of Science ®Google Scholar
• Price RN, Nosten F, Luxemburger C et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet347(9016), 1654–1658 (1996).
   PubMed Web of Science ®Google Scholar
• Drakeley CJ, Akim NI, Sauerwein RW et al. Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Trans. R. Soc. Trop. Med. Hyg.94(5), 472–476 (2000).
   PubMed Web of Science ®Google Scholar
• Sisowath C, Stromberg J, Martensson A et al. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis.191(6), 1014–1017 (2005).
   PubMed Web of Science ®Google Scholar
• Duraisingh MT, Roper C, Walliker D et al. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol.36(4), 955–661 (2000).
   PubMed Web of Science ®Google Scholar
• Price RN, Uhlemann AC, van VM et al. Molecular and pharmacological determinants of the therapeutic response to artemether–lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis.42(11), 1570–1577 (2006).
   PubMed Web of Science ®Google Scholar
• Mutabingwa TK, Anthony D, Heller A et al. Amodiaquine alone, amodiaquine+sulfadoxine–pyrimethamine, amodiaquine+artesunate, and artemether–lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet365(9469), 1474–1480 (2005).
   PubMed Web of Science ®Google Scholar
• Piola P, Fogg C, Bajunirwe F et al. Supervised versus unsupervised intake of six-dose artemether–lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet365(9469), 1467–1473 (2005).
   PubMed Web of Science ®Google Scholar
• Karema C, Fanello CI, Van OC et al. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans. R. Soc. Trop. Med. Hyg.100(12), 1105–1111 (2006).
   PubMed Web of Science ®Google Scholar
• Obonyo CO, Juma EA, Ogutu BR et al. Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis. Trans. R. Soc. Trop. Med. Hyg.101(2), 117–126 (2007).
   PubMed Web of Science ®Google Scholar
• Newton PN, McGready R, Fernandez F et al. Manslaughter by fake artesunate in Asia – will Africa be next? PLoS Med.3(6), E197 (2006).
   PubMed Web of Science ®Google Scholar
• Barnes KI, Little F, Smith PJ et al. Sulfadoxine–pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Clin. Pharmacol. Ther.80(6), 582–596 (2006).
   PubMed Web of Science ®Google Scholar
• Schellenberg D, Menendez C, Kahigwa E et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet357(9267), 1471–1477 (2001).
   PubMed Web of Science ®Google Scholar
• Schellenberg D, Menendez C, Aponte JJ et al. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet365(9469), 1481–1483 (2005).
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans. R. Soc. Trop. Med. Hyg.94(Suppl. 1), S1–S90 (2000).
   PubMed Web of Science ®Google Scholar
• Ackerman H, Usen S, Jallow M et al. A comparison of case-control and family-based association methods: the example of sickle-cell and malaria. Ann. Hum. Genet.69(Pt 5), 559–565 (2005).
   PubMed Web of Science ®Google Scholar
• Mockenhaupt FP, Ehrhardt S, Gellert S et al. α+-thalassemia protects African children from severe malaria. Blood104(7), 2003–2006 (2004).
   PubMed Web of Science ®Google Scholar
• Roberts DJ, Williams T. Hemoglobinopathies and resistance to malaria. Redox Rep.8, 304–310 (2003).
   PubMed Web of Science ®Google Scholar
• Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet.77(2), 171–192 (2005).
   PubMed Web of Science ®Google Scholar
• Patnaik P, Jere CS, Miller WC et al. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J. Infect. Dis.192(6), 984–991 (2005).
   PubMed Web of Science ®Google Scholar
• French N, Nakiyingi J, Lugada E et al. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS15(7), 899–906 (2001).
   PubMed Web of Science ®Google Scholar
• Grimwade K, French N, Mbatha DD et al. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS18(3), 547–554 (2004).
   PubMed Web of Science ®Google Scholar
• Montgomery J, Milner DA Jr, Tse MT et al. Genetic analysis of circulating and sequestered populations of Plasmodium falciparum in fatal pediatric malaria. J. Infect. Dis.194(1), 115–122 (2006).
   PubMed Web of Science ®Google Scholar
• Kaestli M, Cockburn IA, Cortes A et al. Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case–control study. J. Infect. Dis.193(11), 1567–1574 (2006).
   PubMed Web of Science ®Google Scholar
• Marsh K, Forster D, Waruiru C et al. Indicators of life-threatening malaria in African children. N. Engl. J. Med.332(21), 1399–1404 (1995).
   PubMed Web of Science ®Google Scholar
• Taylor TE, Molyneux ME, Wirima JJ et al. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N. Engl. J. Med.319(16), 1040–1047 (1988).
   PubMed Web of Science ®Google Scholar
• Molyneux ME, Taylor TE, Wirima JJ et al. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q. J. Med.71(265), 441–459 (1989).
   PubMedGoogle Scholar
• Kihara M, Carter JA, Newton CR. The effect of Plasmodium falciparum on cognition: a systematic review. Trop. Med. Int. Health11(4), 386–397 (2006).
   PubMed Web of Science ®Google Scholar
• Crawley J, Smith S, Kirkham F et al. Seizures and status epilepticus in childhood cerebral malaria. Q. J. Med.89(8), 591–597 (1996).
   Google Scholar
• Crawley J, Waruiru C, Mithwani S et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet355(9205), 701–706 (2000).
   PubMed Web of Science ®Google Scholar
• English M, Waruiru C, Amukoye E et al. Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. Am. J. Trop. Med. Hyg.55(5), 521–524 (1996).
   PubMed Web of Science ®Google Scholar
• Maitland K, Levin M, English M et al. Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. Q. J. Med.96(6), 427–434 (2003).
   Google Scholar
• Maitland K, Pamba A, English M et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin. Infect. Dis.40(4), 538–545 (2005).
   PubMed Web of Science ®Google Scholar
• Akech S, Gwer S, Idro R et al. Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin. Trials1(5), E21 (2006).
   PubMedGoogle Scholar
• Phu NH, Hien TT, Mai NT et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N. Engl. J. Med.347(12), 895–902 (2002).
   PubMed Web of Science ®Google Scholar
• Berkley JA, Lowe BS, Mwangi I et al. Bacteremia among children admitted to a rural hospital in Kenya. N. Engl. J. Med.352(1), 39–47 (2005).
   PubMed Web of Science ®Google Scholar
• Graham SM, Walsh AL, Molyneux EM et al. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans. R. Soc. Trop. Med. Hyg.94(3), 310–314 (2000).
   PubMed Web of Science ®Google Scholar
• The Artemether-Quinine Meta-analysis Study Group. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg.95(6), 637–650 (2001).
   PubMed Web of Science ®Google Scholar
• Dondorp A, Nosten F, Stepniewska K et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet366(9487), 717–25 (2005).
   PubMed Web of Science ®Google Scholar
• Barennes H, Balima-Koussoube T, Nagot N et al. Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial. Br. Med. J.332(7549), 1055–1059 (2006).
   PubMedGoogle Scholar
• Barnes KI, Mwenechanya J, Tembo M et al. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet363(9421), 1598–1605 (2004).
   PubMed Web of Science ®Google Scholar
• Karunajeewa HA, Reeder J, Lorry K et al. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea. Antimicrob. Agents Chemother.50(3), 968–974 (2006).
   PubMed Web of Science ®Google Scholar
• Aceng JR, Byarugaba JS, Tumwine JK. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. Br. Med. J.330(7487), 334 (2005).
   PubMed Web of Science ®Google Scholar
• Pussard E, Straczek C, Kabore I et al. Dose-dependent resorption of quinine after intrarectal administration to children with moderate Plasmodium falciparum malaria. Antimicrob. Agents Chemother.48(11), 4422–4426 (2004).
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ellis JC, Kamwendo H et al. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet367(9522), 1591–7 (2006).
   PubMed Web of Science ®Google Scholar
• Eisele TP, Lindblade KA, Wannemuehler KA et al. Effect of sustained insecticide-treated bed net use on all-cause child mortality in an area of intense perennial malaria transmission in western Kenya. Am. J. Trop. Med. Hyg.73(1), 149–156 (2005).
   PubMed Web of Science ®Google Scholar
• Alonso PL, Sacarlal J, Aponte JJ et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet364(9443), 1411–1420 (2004).
   PubMed Web of Science ®Google Scholar
• Alonso PL, Sacarlal J, Aponte JJ et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet366(9502), 2012–2018 (2005).
   PubMed Web of Science ®Google Scholar